The team headed by Professor Zhang Hongjie (3rd from left), Director of the Teaching and Research Divsion of SCM, has become the first HKBU team to be supported by the Health and Medical Research Fund (HMRF) administered by the Food and Health Bureau to conduct research addressing COVID-19. Titled “Development of resveratrol and its congeners as preventive and therapeutic agents for control of COVID-19”, the project has received over HK$2.8 million in funding from HMRF. It is one of the many initiatives taken by Professor Zhang to explore and identify novel antiviral agents from natural resources against emerging and re-emerging viruses threatening the human race.
© School of Chinese Medicine, Hong Kong Baptist University. All Rights Reserved.